supplementary figures, from In-depth Clinical and Biological Exploration of DNA Damage Immune Response as a Biomarker for Oxaliplatin Use in Colorectal Cancer

Malla SB., Fisher DJ., Domingo E., Blake A., Hassanieh S., Redmond KL., Richman SD., Youdell M., Walker SM., Logan GE., Chatzipli A., Amirkhah R., Humphries MP., Craig SG., McDermott U., Seymour MT., Morton DG., Quirke P., West NP., Salto-Tellez M., Kennedy RD., Johnston PG., Tomlinson I., Koelzer VH., Campo L., Kaplan RS., Longley DB., Lawler M., Maughan TS., Brown LC., Dunne PD.